Bristol-Myers Squibb
BMY
BMY
1,445 hedge funds and large institutions have $80.7B invested in Bristol-Myers Squibb in 2015 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 485 increasing their positions, 610 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% less funds holding
Funds holding: 1,447 → 1,445 (-2)
20% less repeat investments, than reductions
Existing positions increased: 485 | Existing positions reduced: 610
22% less call options, than puts
Call options by funds: $558M | Put options by funds: $717M
Holders
1,445
Holding in Top 10
80
Calls
$558M
Puts
$717M
Top Buyers
| 1 | +$1.27B | |
| 2 | +$405M | |
| 3 | +$245M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$182M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$173M |
Top Sellers
| 1 | -$353M | |
| 2 | -$220M | |
| 3 | -$172M | |
| 4 |
O
OppenheimerFunds
New York
|
-$146M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$132M |